Discover Editas Medicine's groundbreaking patent for enzymatically active Cas9 fusion molecules, enhancing gene editing precision with innovative nucleic acid applications.

RNA interference (RNAi) technology has gradually become a cutting-edge technology for treating diseases such as genetic ...

RNA interference (RNAi) technology has gradually become a cutting-edge technology for treating diseases such as genetic disorders and cancer due to ...

Ongoing research is exploring new molecular targets and targeted therapies for this challenging disease.

Many cancer types are caused by gene fusions that bring together parts of two different genes, often changing the activity of one of the partners. Although fusion transcripts result from structural ...

Throughlines in Scandinavian and Japanese design include clean lines, a strong connection to nature, minimalism and a ...

Illumina’s TSO Comprehensive is FDA-approved as a CDx to identify adult and pediatric patients with solid tumors who are positive for neurotrophic tyrosine receptor kinase (NTRK) gene fusions ...

TSO Comprehensive is FDA approved as a CDx to identify adult and pediatric patients with solid tumors who are positive for neurotrophic tyrosine receptor kinase (NTRK) gene fusions that may benefit ...

Larimar will present three posters during the conference, one of which will also be presented as an oral presentation. The poster presentations are as follows: Effect of nomlabofusp administration on ...